WHO Advises Against Use of Remdesivir on COVID Patients
Published
Clinical trials show there currently is no evidence the antiviral drug improves survival of patients, no matter how severely ill they are
Full ArticlePublished
Clinical trials show there currently is no evidence the antiviral drug improves survival of patients, no matter how severely ill they are
Full ArticleKey drug candidate lenzilumab is a recombinant monoclonal antibody Designed to reduce sometimes dangerous side effects associated..
The first case of novel Coronavirus -- SARS-CoV2 -- was reported on November 17, 2019, in China's Wuhan city, and in March, the WHO..